Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-12
2006-12-12
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S193100, C424S198100, C530S300000, C530S326000, C530S399000
Reexamination Certificate
active
07148193
ABSTRACT:
The present invention provides peptides that bind to the active site of the growth hormone receptor. The present invention also provides methods of using these peptides to identify small organic molecules, which are novel agonists or antagonists of the growth hormone receptor. In addition, the present invention provides kits and therapeutic compositions comprising the peptides that bind to growth hormone receptor.
REFERENCES:
patent: 6387879 (2002-05-01), Blume et al.
degli Unerti EC, Trasforini G, Salvadori S, Margutti A, Tomatis R, Rotola C, Bianconi M, Pansini R. “Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion”Neuroendocrinology, Oct. 1983, 37(4):280-3.
Luvnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA. “Functional mimicry of a protein hormone by a peptide agonist: the WPO receptor complex at 2.8 A.”Science. Jul. 26, 1996, 273(5274):464-71.
Eason MG, Francis RS, Kuhn CM. “mu-Opioid agonists stimulate growth hormone secretion in immature rats”Neuroendocrinology, Jun. 1996, 63(6):489-97.
Muruais J, Penalva A, Dieguez C, Casanueva FF. “Infuence of endogenous cholinergic tone and alpha-adreneric pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog”J Endocrinol.Aug. 1993, 138(2):211-8.
Wells JA. “Hormone mimicry”Science, Jul. 26, 1996, 273(5274):449-50.
Moore GJ. “Discovery and design of peptide mimetics”Proc West Pharmacol Soc.1997;40:115-9.
Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. “Small peptides as a potent mimetics of the protein hormone erythropoietin”Science. Jul. 26, 1996, 273(5274):458-64.
Braisted A. “Hormone peptidomimetics:seeing double”Nat Biotechnol.Nov. 1997, 15(12):1244-5.
Hruby VJ, Ahn JM, Liao S. “Synthesis of oligopeptide and peptidomimetic libraries”Curr Opin Chem Biol.Jun. 1997;1(1):114-9.
Kieber-Emmons T, Murali R, Greene MI, “Therapeutic peptides and peptidomimetics”Curr Opin Biotechnol.Aug. 1997; 8(4):435-41.
Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW, Balasubramanian P, Chino Jp, Cwirla SE, Peters-Bhatt E, Whitehorn EA, Tate EH, Akeson A, Bowlin TL, Dower WJ, Barrett RW. “High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libaries”Proc Natl Acad Sci U S A. Jul. 9, 1996, 93(14):7381-6.
Cwirls SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LS, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ, “Pepetide agonist of the thrombopoietin receptor as potent as the natural cytokine”Science.Jun. 13, 1997, 276(5319):1696-9.
Katz BA. “Structural and mechanistic derterminants of affinity and specificity of ligands discovered or engineered by phage display”Annu Rev Biophys Biomol Struct.1997; 26:27-45.
F. Martin, C. Toniatti, A.L. Salvati, S. Venturini, G. Ciliberto, R. Cortese, M. Sollazo, 1994, “The affinity-selection of minibody polypeptide inhibitor of human interleukin-6”EMBO J.13:5303-5309.
B.S. Wang, A.L. Lumanglas, C.A. Bona, T.M. Morna, 1996, “Functional characterization of monoclonal antibodies specific to growth hormone receptor”Mol. immunol.33:1197-1202.
C.D. Partidos, C.L. Chirinos-Rojas, M.W. Steward, 1997, “The potential of comibnatorial peptide libraries for the indetification of inhibitors of THF-α mediated cytotxicity in vitro”Immunol. Lett.57:113-116.
S.C. Souza, G.P. Frick, X. Wang, J.J. kopchick, R.B. Lobo, H.M. Goodman, 1995, “A single arginine residue determines species specificity of the human growth hormone”Proc. Natl. Acad, Sci. USA92:959-963.
Z. Guo, D. Zhou, P.G. Schultz, 2000, “Designing small-molecule switches for protein-protein interactions”Science288:2042-2045.
U.S. Appl. No. 08/990,888, filed Dec. 15, 1997, Blume et al.,
Blume Arthur J.
Brissette Renee
Carcamo Juan
Mandecki Wlodek S.
Tang Pauline M.
Antyra Inc.
Morgan & Finnegan L.L.P.
Tsay Marsha
Wax Robert A.
LandOfFree
Compounds that bind to growth hormone receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that bind to growth hormone receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that bind to growth hormone receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3656087